BioLife Solutions is poised to benefit from the booming cell and gene therapy sector. Read more to see my investment strategy ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...

Sarepta Therapeutics said on Friday it had temporarily halted three trials testing its gene therapy Elevidys, following the death of a patient last month upon receiving the treatment.

Bain Capital’s Life Sciences team led the funding round, with contributions from new investor Wellington Management.

Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to ...

The $150 million will also go toward Atsena’s preclinical pipeline and expand the use of the biotech’s spreading AAV.SPR ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

In response to a request from the European Medicines Agency (EMA) following the death of a 16-year-old patient in the U.S., ...